Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute on Drug Abuse (NIDA)
With
New York MDRU
The objective of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.
Age
21–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male/Female between the ages of 21 and 45. Within 15% of ideal body weight. No oral pathology that would interfere with the sublingual absorption of the medication. Experienced in the use of opiates but not dependent.
You may not be if
LFT's exceeding than 3x's normal. History of seizure. Opiate dependent.
